IEC 60601-1-2

IEC 60601-1-2 is the electromagnetic-compatibility collateral standard within the IEC 60601 family. It addresses the basic safety and essential performance of medical electrical equipment and medical electrical systems when exposed to electromagnetic disturbances. It also addresses electromagnetic disturbances generated by that equipment.

The standard supplements IEC 60601-1 rather than replacing it. Product-specific particular standards, other collateral standards, risk-management requirements, and regional regulatory rules may introduce additional or modified requirements.

The compliance strategy is based on the intended electromagnetic environment. Typical classifications include professional healthcare facilities, home healthcare environments, and special environments. A special environment may require test levels or mitigation measures derived from a product-specific electromagnetic risk assessment.

Compliance is therefore more than completing a fixed list of laboratory tests. The manufacturer must identify essential performance, define observable pass/fail criteria, document intended operating environments, evaluate foreseeable electromagnetic disturbances, and demonstrate that unacceptable risks are adequately controlled.

The standard applies broadly to medical electrical equipment and medical electrical systems covered by the IEC 60601 series. Examples may include patient monitors, diagnostic instruments, therapeutic equipment, infusion systems, ventilatory equipment, imaging-system components, electrically powered hospital equipment, and medical devices intended for home use.

Accessories, external power supplies, cables, sensors, network interfaces, wireless modules, and interconnected equipment can affect the final EMC configuration. The tested configuration should therefore represent the marketed system and include the equipment, accessories, cable types, cable lengths, operating modes, and supporting equipment that can create the highest emissions or greatest susceptibility.

Applicability must be established from the product definition and the relevant regulatory pathway. Some products, such as certain in-vitro diagnostic equipment, implantable equipment, laboratory equipment, or non-medical accessories, may be governed primarily by other standards. A product-specific standards assessment should be completed before the test plan is finalized.

International use: IEC 60601-1-2 is an international consensus standard. It becomes legally or contractually relevant when adopted by a regulator, incorporated into a regional standard, required by a certification scheme, or specified by a purchaser. Manufacturers should identify the exact edition and amendments accepted in every target market.

United States: The U.S. Food and Drug Administration recognizes IEC 60601-1-2 Edition 4.1 as a consensus standard, subject to the extent and qualifications stated in the FDA recognition database. The FDA record identifies partial-recognition conditions, so manufacturers should not assume that an unqualified IEC test report addresses every FDA expectation. Current FDA EMC guidance and device-specific requirements should also be considered.

European Union: Manufacturers should confirm the applicable EN adoption, its current harmonization status, and any dates or restrictions listed for the Medical Device Regulation or other relevant legislation. Use of a harmonized standard can support a presumption of conformity only within its published scope and conditions.

Canada: EMC evidence forms part of the overall safety and effectiveness documentation for applicable medical devices. Manufacturers should verify the edition accepted for their submission, the applicable device classification, and any additional Health Canada expectations.

Regional deviations, national adoptions, product-specific standards, radio requirements, and cybersecurity or wireless-coexistence expectations may apply in addition to IEC 60601-1-2.

IEC 60601-1-2 covers both electromagnetic emissions and immunity. The standard uses normative references, including CISPR and IEC 61000 standards, to define the applicable test methods.

Electromagnetic emissions: Conducted and radiated RF emissions are evaluated according to CISPR 11. Harmonic current emissions under IEC 61000-3-2 and voltage fluctuations and flicker under IEC 61000-3-3 apply where applicable.

Electromagnetic immunity: The principal tests include electrostatic discharge (ESD), radiated RF electromagnetic fields, proximity fields from RF wireless communications equipment, electrical fast transients and bursts (EFT), surge, conducted RF disturbances, power-frequency magnetic fields, proximity magnetic fields, and voltage dips, short interruptions, and voltage variations.

The immunity test levels in IEC 60601-1-2 depend on the intended use environment, the applicable port, and the type of electromagnetic disturbance. The table below summarizes key test levels for professional healthcare facility and home healthcare environments.

The radiated RF immunity level is 3 V/m for the professional healthcare facility environment and 10 V/m for the home healthcare environment. For conducted RF immunity, 6 V r.m.s. applies in ISM bands for the professional healthcare facility environment, while ISM and amateur radio bands are considered for the home healthcare environment.

The 30 kHz proximity magnetic-field test applies only to ME equipment and ME systems intended for the home healthcare environment. Power-frequency magnetic-field immunity applies to ME equipment and ME systems containing magnetically sensitive components or circuitry.

Other immunity requirements, including EFT/burst, surge, voltage dips and short interruptions, and proximity fields from RF wireless communications equipment, are specified according to the applicable port and test conditions. These requirements should be evaluated separately rather than applying one test level to all ME equipment and ME systems.

For electromagnetic emissions, IEC 60601-1-2 refers to CISPR 11. ME equipment and ME systems are classified as Group 1 or Group 2 and Class A or Class B.

Group 1 covers equipment that does not intentionally generate or use locally coupled RF energy for its internal function, while Group 2 covers equipment that intentionally generates or uses RF energy. Class A is generally intended for non-residential locations, while Class B is suitable for residential environments and has more restrictive emissions limits.

For example, typical Group 1, Class B equipment measured at 3 m has radiated emissions limits of 40 dBuV/m from 30 MHz to 230 MHz and 47 dBuV/m from 230 MHz to 1 GHz.

ME equipment and ME systems shall be tested in representative configurations consistent with intended use. The configurations and operating modes most likely to result in an unacceptable risk should be selected based on risk analysis, experience, engineering analysis, or pretesting.

During immunity testing, the ME equipment or ME system is evaluated for maintenance of basic safety and essential performance. The functions necessary to demonstrate compliance should be monitored during the test where practicable and, where required, after the application of the electromagnetic disturbance.

Test configurations, operating modes, monitoring methods, and any special test equipment or software should be documented so that the conditions used to demonstrate compliance are clearly defined.

Pre-compliance testing should reproduce the intended use configuration as closely as practical, including representative cables, accessories, patient connections, grounding, and operating modes.

For emissions testing, an artificial hand may be required by CISPR 11 for hand-held equipment or parts that are normally touched during use. The artificial hand simulates the influence of the user’s hand on the electromagnetic emissions measurement and should be applied to the appropriate accessible parts as specified by the test method.

Early testing in representative configurations can help identify emissions or immunity problems before formal compliance testing. Any configuration used for final testing should remain consistent with the intended use and the applicable requirements of IEC 60601-1-2.